Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
172,863
-
Share change
-
+39,523
-
Total reported value
-
$17,292,257
-
Put/Call ratio
-
163%
-
Price per share
-
$100.01
-
Number of holders
-
20
-
Value change
-
+$3,960,921
-
Number of buys
-
12
-
Number of sells
-
4
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q2 2023
As of 30 Jun 2023,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
172,863 shares.
The largest 10 holders included
Bullseye Investment Management, LLC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GTS SECURITIES LLC, GOLDMAN SACHS GROUP INC, Virtu Financial LLC, Traynor Capital Management, Inc., JANE STREET GROUP, LLC, Tower Research Capital LLC (TRC), and Onyx Bridge Wealth Group LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.